knowledge -WSS

knowledge

author：fashion 2025-09-07 04:14:04 - browse：51294

Blue Cross Blue Shield website seen on several laptop screens. -- health business coverage from STAT — Adobe

A program that undergirds the Affordable Care Act’s health insurance marketplaces continues to bolster the balance sheets of large Blue Cross Blue Shield companies, according to a STAT analysis of new federal data.

Conversely, that same program — called “risk adjustment” — has created substantial financial burdens for startup insurers including Bright Health Group, which has now exited all health insurance markets, and Friday Health Plans, which has shut down.

More than two dozen BCBS insurers are projected to collect more than $4.7 billion from competing insurers on the ACA marketplaces, according to the analysis. The biggest amounts are concentrated among a few dominant Blues conglomerates.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： App could help diagnose ear infections more accurately — and at home

WSS

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Bispecific antibodies are next new thing in cancer immunotherapy

Inside the rise of 'mukbang' eating videos

Living organ donors deserve priority status for transplants

Mom launches Girl Scout troop for LGBTQ youth in Texas

Bispecific antibodies are next new thing in cancer immunotherapy

Wikipedia

knowledge

focus

ChatGPT in medicine: STAT answers readers' burning questions

Novo pauses ads for weight loss drug Wegovy amid demand

The high cost of giving birth even with insurance

Patients, doctors are clashing about side effects of hormonal birth control

Alkermes shareholders re

SCOTUS questions limit to govt efforts to fight misinformation

New air purifier tech could be key to improving indoor air quality

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly’s Mounjaro succeeds in second weight

hotspot

Bispecific antibodies are next new thing in cancer immunotherapy

Intermittent fasting comes with a heart risk? Not so fast

SCOTUS questions limit to govt efforts to fight misinformation

Methadone treatment changes are coming. Do they go far enough?

Senate panel passes drug pricing bills, but drops one PBM reform

Biogen nominates mother of director’s child to replace him on board

hotspot

knowledge

hotspot

focus